Ingreso a España


A partir del 07 de junio de 2021 todos los pasajeros de 12 años o más procedentes de un país o zona de riesgo de los enumerados a continuación deben disponer de una de las opciones:

Certificado de Vacunación:

  • Se aceptarán certificados de vacunación emitidos por las autoridades competentes después de 14 días después de la administración de la última dosis necesaria para completar el ciclo de vacunación.
  • Se aceptarán las vacunas autorizadas por la Agencia Europea del Medicamento (EMA) y aquellas que haya completado el proceso de uso de emergencia de la Organización Mundial de la Salud. De momento, se aceptan las siguientes vacunas: Comirnaty (Pzfizer-Biontech) – Moderna – Vaxzeria (Astra-Zeneca) – Covishield – Janssen/Johnson&Johnson – Sinovac (Coronavac) – Sinopharm.
  • El certificado debe incluir, al menos, la siguiente información: nombre y apellido del titular; fecha de vacunación, indicando la fecha de la última dosis administrada; tipo de vacuna administrada; número de dosis administradas/pauta completa; país emisor; identificación del organismo emisor del certificado de vacunación.

Nota: Sólo se permitirá la entrada por turismo a pasajeros procedentes de países no incluidos en la lista de países exentos si cuentan con un certificado de vacunación emitido de acuerdo con las condiciones de este apartado.

Excepción: En el caso de pasajeros residentes en Reino Unido que procedan directamente de él:

  • Nacionales y residentes en el Reino Unido en viaje de turismo: además del certificado de vacunación, serán considerados válidos también las pruebas NAAT autorizadas para viajes no esenciales. No se aceptan pruebas de antígenos ni certificado de recuperación.
  • Ciudadanos UE y nacionales y residentes en el Reino Unido en viaje esencial: Se aceptan certificados de vacunación, pruebas diagnósticas (prueba NAAT y prueba de antígenos) y certificados de recuperación.

Prueba Diagnóstica de Infección Activa (PDIA) para SARS-CoV-2 con resultado negativo:

  • Prueba de amplificación de ácido nucleico molecular (NAAT), cuya muestra haya sido obtenida dentro de las 72 horas anteriores a la llegada a España. Se aceptarán pruebas moleculares como: RT-PCR, RT-LAMP, TMA y otras pruebas basadas en técnicas moleculares equivalentes.
  • Prueba de detección de antígeno para CoVID-19, cuya muestra haya sido obtenida dentro de las 48 horas anteriores a la llegada a España. Se aceptarán los antígenos aprobados por la UE.
  • No se admitirán otras pruebas diagnósticas tales como test rápidos de anticuerpos o serologías de alto rendimiento (ELISA, CLIA, ECLIA).
  • El documento de la PDIA debe ser el original, estará en papel o formato electrónico y contendrá el nombre y apellido del titular, fecha de la toma de la muestra, tipo de prueba realizada, país emisor.

Certificado de Recuperación:

  • Se aceptarán los certificados emitidos por la autoridad competente o servicio médico por lo menos 11 días después de la primera prueba (NAAT) diagnóstica positiva.
  • La validez del certificado finalizará a los 180 días a partir de la fecha de la toma de la muestra.
  • El certificado de recuperación deberá incluir, al menos, la siguiente información: nombre y apellido del titular, fecha de la toma de muestras de la primera prueba diagnóstica positiva para SARS-CoV-2, tipo de prueba NAAT realizada, país emisor.
  • Es posible que alguna persona que quiere viajar a España tenga una PCR persistentemente positiva tras haber pasado la enfermedad, estando ya curados y no siendo contagiosos. En estos casos verifique la siguiente documentación:
    • Certificado de su última PCR, realizada en las 72 horas anteriores a su llegada a España.
    • Informe clínico en el que se indique expresamente que la persona está curada y no es contagiosa pese a tener una PCR positiva. En el informe deberá estar expresamente escrita una frase similar a la siguiente: "Don / Doña XXXXX puede viajar en avión, al no ser contagioso/a, a pesar de presentar una PCR positiva de CoVID-19”. 

La lista de países / áreas de alto riesgo puede obtenerse en: https://www.mscbs.gob.es

No se exigirá PDIA, certificado de vacunación o certificado de recuperación a pasajeros procedentes de países no incluidos en la lista.

Se efectuará prueba de antígenos a todos los pasajeros procedentes de Brasil y Sudáfrica.

Todos los pasajeros que lleguen a España por vía aérea (incluyendo pasajeros en tránsito internacional con destino final en otro país) deben cumplimentar un Formulario de Control Sanitario (FCS), a través de la web o de la aplicación "Spain Travel Health-SpTH". Una vez se ha cumplimentado el formado, cada pasajero obtendrá un código QR asociado al viaje, que debe presentarse a UX antes del embarque y a las Autoridades a la llegada en España: 

Formulario de Control Sanitario 

Los pasajeros procedentes de países o zonas no incluidos en la relación de países de riesgo deberán cumplimentar FCS a través de SpTH y obtendrán un código QR con la denominación “FAST CONTROL” que permitirá que los procesos de control sanitario a la llegada se hagan de una forma más ágil.

El asiento en el FCS es obligatorio, pero se puede modificar hasta en la llegada (genera un nuevo código QR al pasajero).

Se denegará el embarque a los pasajeros:

  • Que no presenten código QR ya que los pasajeros sin código QR serán inadmitidos a la llegada con las obligaciones correspondientes y penalizaciones para UX.
  • Que estén en posesión de un código QR identificado como ‘DOCUMENTAL CONTROL’ y no proporcionen certificado de vacunación, de prueba diagnóstico o recuperación.

Exceptuados: miembros de la tripulación en servicio y miembros de la tripulación en vuelos de situación viajando con las evidencias correspondientes de la compañía.

Proceso de verificación en la estación de origen:

  • Se comprobará antes de permitir el embarque que los pasajeros disponen del código QR generado (en formato digital o papel – esto significa que los clientes pueden llevar también su código QR impreso en papel).
  • El código QR también es obligatorio para tránsitos en conexión.


Ingreso a Francia


Importante: NO está permitida la entrada de turistas a Francia con 2 dosis de la vacuna SINOPHARM .  Pasajeros vacunados con SINOPHARM solo podrán entrar a Francia 7 días después de haber recibido una tercera dosis de la vacuna Pfizer o Moderna.


  •  Test: 

Unvaccinated passengers: Passengers aged 12 years and older must hold either a negative result of a biological examination of virological screening (RT-PCR, PCR, qRT-PCR, qPCR, RT-LAMP, LAMP, TMA or detection of RNA only) where the test is carried out less than 72 hours prior to boarding, or a negative result of a biological test (antigenic test) enabling the detection of the N protein of SARS-COV-2 where the test is carried out less than 48 hours prior to boarding. Please note that negative test results issued by the National Health Service (NHS) in the United Kingdom or by HSE (Irish Health Service) in Ireland are not accepted for travel.

Vaccinated passengers: Test is not required for passengers who hold proof they are fully vaccinated. Passengers are considered fully vaccinated either 28 days after the first dose of Johnson & Johnson vaccine, or 7 days after the second dose of AstraZeneca (Vaxzevria, Covishield, R-Covi, Fiocruz), Moderna, or Pfizer-BioNTech vaccine. For passengers with proof of Covid-19 infection prior to vaccination, passengers are fully vaccinated 7 days after the first dose of these vaccines. For passengers who have received a vaccine not authorized by France but approved vaccine recognized by the World Health Organization (WHO), passengers are fully vaccinated 7 days after receiving a dose of Moderna or Pfizer-BioNTech vaccine.

Other exempt passengers: 

    1. Passengers who hold a certificate of recovery with a positive test result obtained between 11 days and 6 months before travel proving that they have recovered from Covid-19;
    2. Transit passengers with a connecting flight to a country outside of the Schengen Area, provided they are also departing from another country that is outside of the Schengen Area. Transit passengers departing from a country outside of the Schengen Area must still hold a test result if they are travelling to another Schengen Area member state, and transiting in France for longer than 24 hours; 
    3. Passengers who continue their journey to a Schengen Area member state, provided that they pass through the Unique Filter Inspection (IFU) (the transit area in the passenger zone between T2E and T2F) and the duration of the transit is less than 24 hours. If the transit to a Schengen Area country requires entry to France, the French entry restrictions apply;
    4. Crew members or personnel necessary for operation of passenger or cargo flights (including when travelling as passengers to or from their departure base); or
    5. Members of diplomatic or official delegation, and staff of international organisations with offices located in France, including their spouses and children.

 

 

  •  Test on Arrival: Passengers aged 12 years and older may be subject to a random antigen test on arrival.

This does not apply to:

    1. Passengers who present a Covid-19 vaccination certificate demonstrating that at least 4 weeks have elapsed since the first dose of Johnson and Johnson vaccine or 1 week have elapsed since the second dose of the AstraZeneca (Covishield), Moderna, or Pfizer-BioNTech vaccine; or
    2. Passengers in transit for less than 24 hours, provided they do not leave the transit area.

 

 

  • Form: 
  • Unvaccinated passengers: Passengers are not permitted to travel if they do not hold a Travel Certificate to Enter Metropolitan France attesting that they have a compelling reason to be admitted into metropolitan France. The travel certificate and supporting documents must be shown before boarding and upon arrival.
  • Vaccinated passengers: Travel certificate is not required for fully vaccinated passengers with a Covid-19 vaccination certificate, or minors accompanying one or more vaccinated adult passengers. Passengers are considered fully vaccinated either 28 days after the first dose of Johnson and Johnson vaccine, or 7 days after the second dose of AstraZeneca (Vaxzevria, Covishield, R-Covi, Fiocruz), Moderna, or Pfizer-BioNTech vaccine. For passengers with proof of Covid-19 infection prior to vaccination, passengers are fully vaccinated 7 days after the first dose of these vaccines. For passengers who have received a vaccine not authorized by France but approved vaccine recognized by the World Health Organization (WHO), passengers are fully vaccinated 7 days after receiving a dose of Moderna or Pfizer-BioNTech vaccine.

 

Mask Required: Double masks must be worn by all passengers arriving at or departing from airports in Peru at all times. Plastic face shields are also recommended.

 

 

 

 

Mask: All passengers must wear a surgical mask (or a filtering face piece mask FFP1, FFP2 or FFP3, provided it does not include a valve) in the airport and during their flight. Passengers will be denied boarding if not wearing a surgical mask.

This does not apply to the following passengers:

  1. Children aged under 11 years;
  2. Passengers with medical exemptions, provided holding a medical certificate.

 

Quarantine on Arrival: 

Unvaccinated passengers: 7 day quarantine for passengers aged 12 years and older. 

Vaccinated passengers: Quarantine is not required for fully vaccinated passengers with a Covid-19 vaccination certificate, or minors accompanying one or more vaccinated adult passengers. Passengers are considered fully vaccinated either 28 days after the first dose of Johnson and Johnson vaccine, or 7 days after the second dose of AstraZeneca (Vaxzevria, Covishield, R-Covi, Fiocruz), Moderna, or Pfizer-BioNTech vaccine. For passengers with proof of Covid-19 infection prior to vaccination, passengers are fully vaccinated 7 days after the first dose of these vaccines. For passengers who have received a vaccine not authorized by France but approved vaccine recognized by the World Health Organization (WHO), passengers are fully vaccinated 7 days after receiving a dose of Moderna or Pfizer-BioNTech vaccine.

 


Ingreso a Países Bajos



  • Test: Long-term positive passengers aged 13 years and older are exempt from holding a negative NAAT test result obtained prior to arrival, provided they are holding all of the following: 
    1. A positive NAAT test result that is between 2 weeks and 8 weeks old;
    2. A positive NAAT test result that is not older than 72 hours before arrival in the Netherlands; and
    3. A negative rapid test result that is not older than 24 hours before boarding.

In case of a permanently positive test result from the rapid test, passengers are permitted to travel if they are holding all of the following: 

    1. A positive NAAT test result that is between 2 weeks to 8 weeks old;
    2. A positive NAAT test result that is not older than 72 hours before arrival in the Netherlands; and
    3. A signed doctor's statement obtain within 72 hours before boarding which confirms that the passenger is no longer contagious.
  •  Test:

Unvaccinated passengers: Passengers aged 12 years and older travelling from a safe country/region outside the EU/Schengen area must hold a negative Covid-19 NAAT test (PCR, RT PCR, LAMP, TMA and mPOCT) result conducted up to 48 hours before boarding or a negative antigen test result conducted up to 24 hours before boarding.

Vaccinated passengers: Test is not required for passengers who hold proof of being fully vaccinated with vaccines approved by the European Medicines Agency (EMA) or the WHO Emergency Use Listing for at least 14 days (please note that for passengers who have been vaccinated with the Johnson and Johnson vaccine after 14 August 2021, proof of vaccination is not valid until 28 days after vaccination).

Other exempt passengers:

    1. Passengers in transit;
    2. Passengers travelling on behalf of the Minister or State Secretary of Justice and Security. This applies in particular to flights where KMAR personnel are accompanying a person to or from the Netherlands;
    3. Passengers with a statement from the Ministry of Health, Welfare and Sport in the context of urgent medical transport;
    4. (Incoming) staff of diplomatic and consular representations or international organisations in the Netherlands who will be registered with the Ministry of Foreign Affairs, including members of their official household;
    5. Heads of state and members of foreign governments;
    6. Crew members on aircrafts, cruise ships and ferries provided they are travelling in the exercise of their work;
    7. Seafarers holding a seafarer's record book who are travelling to the Netherlands on passenger transport in connection with their work;
    8. Transport workers and seafarers travelling to or from their work in the Netherlands;
    9. Essential transport personnel who are travelling to the Netherlands on passenger transport in connection with their work, including lorry drivers, crew members on container ships, bulk carriers (such as ore and coal), tankers (fuel and chemicals) and fishing vessels;
    10. Passengers with a NATO Travel Order or a NATO-2 visa;
    11. Passengers working on oil and gas platforms, offshore wind farms and offshore companies that provide services to the energy sector, who are travelling on passenger transport in connection with their work; or
    12. Passengers diverted to a Dutch airport whose original destination is not the Netherland.   

More details can be read online here.


  •  Form: Passengers aged 13 years and older travelling to and from Netherlands are required to fill in a Health Declaration form. An example of the form can be found online here.

A paper form is not required for passengers travelling to or from Amsterdam. These passengers can submit the form online.

This does not apply to passengers in transit.


Mask Required: Double masks must be worn by all passengers arriving at or departing from airports in Peru at all times. Plastic face shields are also recommended.

  •  Mask: All passengers aged 13 and older must wear a face mask in the airport and during their flight.